Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Diphtheria and tetanus toxoids adsorbed (DT) when administered to individuals younger than 7 years, for intramuscular use

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 90702 refers to the administration of diphtheria and tetanus toxoids adsorbed (DT) specifically for individuals who are younger than 7 years of age. This vaccine is administered via intramuscular injection and is designed to provide long-lasting immunity against the diseases caused by the toxins produced by the bacteria responsible for diphtheria and tetanus. Toxoids are inactivated forms of the toxins that stimulate the immune system to produce antibodies, which are crucial for neutralizing the harmful effects of these toxins. The process of creating a toxoid involves culturing the bacteria in a controlled liquid medium, followed by purification and inactivation of the toxin produced. It is important to note that since toxoids are not live vaccines, the immunity they confer can diminish over time, necessitating booster doses to maintain adequate protection. The code 90702 specifically reports the use of the diphtheria and tetanus toxoids (DT) product administered to eligible patients, emphasizing its role in immunization for young children.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The administration of diphtheria and tetanus toxoids adsorbed (DT) is indicated for the immunization of individuals younger than 7 years. This vaccine is crucial for protecting against the diseases caused by the toxins of diphtheria and tetanus, which can lead to severe health complications if contracted. The primary indications for this procedure include:

  • Immunization against Diphtheria - Diphtheria is a serious bacterial infection that affects the mucous membranes of the throat and nose, leading to difficulty breathing, heart failure, and even death.
  • Immunization against Tetanus - Tetanus, also known as lockjaw, is a potentially fatal disease caused by a toxin produced by the bacterium Clostridium tetani, leading to painful muscle stiffness and spasms.
  • Routine Childhood Vaccination - The DT vaccine is part of the standard immunization schedule for children, ensuring they develop immunity before they are exposed to these diseases.

2. Procedure

The procedure for administering diphtheria and tetanus toxoids adsorbed (DT) involves several key steps to ensure safety and efficacy. Each step is critical to the successful immunization of the patient.

  • Step 1: Patient Assessment - Prior to administration, the healthcare provider assesses the patient's medical history, including any previous allergic reactions to vaccines, current health status, and vaccination history to determine eligibility for the DT vaccine.
  • Step 2: Preparation of the Vaccine - The diphtheria and tetanus toxoids are prepared according to the manufacturer's guidelines. This includes checking the expiration date, ensuring proper storage conditions, and shaking the vial gently to mix the contents if necessary.
  • Step 3: Site Selection and Preparation - The healthcare provider selects an appropriate intramuscular injection site, typically the anterolateral thigh for infants and young children. The site is cleaned with an antiseptic wipe to reduce the risk of infection.
  • Step 4: Administration of the Vaccine - Using a sterile syringe and needle, the provider administers the DT vaccine intramuscularly. The injection is given at a 90-degree angle to ensure proper delivery into the muscle tissue.
  • Step 5: Post-Administration Care - After the injection, the provider monitors the patient for any immediate adverse reactions, such as allergic responses. The patient or guardian is given information on potential side effects and the importance of follow-up doses.

3. Post-Procedure

Post-procedure care for the administration of diphtheria and tetanus toxoids adsorbed (DT) includes monitoring the patient for any immediate side effects, which may include mild fever, soreness at the injection site, or irritability. It is essential to inform the patient or guardian about these potential reactions and to advise them on when to seek medical attention. Additionally, the importance of completing the full vaccination series, including any necessary booster doses, should be emphasized to ensure long-term immunity against diphtheria and tetanus. Documentation of the vaccine administration, including the date, lot number, and site of injection, is also crucial for maintaining accurate medical records.

Short Descr DT VACCINE UNDER 7 YRS IM
Medium Descr DT VACCINE YOUNGER THAN 7 YRS FOR IM USE
Long Descr Diphtheria and tetanus toxoids adsorbed (DT) when administered to individuals younger than 7 years, for intramuscular use
Status Code Excluded from Physician Fee Schedule by Regulation
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Items and Services Packaged into APC Rates
Type of Service (TOS) 1 - Medical Care
Berenson-Eggers TOS (BETOS) O1G - Immunizations/Vaccinations
MUE 1
CCS Clinical Classification 228 - Prophylactic vaccinations and inoculations
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
GA Waiver of liability statement issued as required by payer policy, individual case
GZ Item or service expected to be denied as not reasonable and necessary
JZ Zero drug amount discarded/not administered to any patient
SL State supplied vaccine
Date
Action
Notes
2016-01-01 Changed First appearance of change in codebook.
2015-07-01 Changed Description Changed
2013-01-15 Changed Corrected short and medium descriptions per AMA corrections document dated 2013-01-15.
2013-01-01 Changed Description Changed
2011-01-01 Changed Short description changed.
2008-01-01 Changed Code description changed.
2007-01-01 Changed Code description changed.
2005-01-01 Changed Code description changed.
2001-01-01 Changed Code description changed.
Pre-1990 Added Code added.
Code
Description
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"